Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Natera, Inc. (NTRA : NSDQ)

• Company Description    Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. Number of Employees: 4,434

• Price / Volume Information    Yesterday's Closing Price: $192.51 Daily Weekly Monthly 20 Day Moving Average: 1,144,558 shares Shares Outstanding: 137.25 (millions) Market Capitalization: $26,421.61 (millions) Beta: 1.74 52 Week High: $196.77 52 Week Low: $117.27 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 17.63% 14.39% 12 Week 44.03% 34.44% Year To Date 21.61% 7.52%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 13011 McCallen Pass Building A Suite 100 - Austin,TX 78753 USA ph: 650-980-9190 fax: - investor@natera.com http://www.natera.com

• General Corporate Information    Officers Steve Chapman - Chief Executive Officer and President Matthew Rabinowitz - Executive Chairman Michael Brophy - Chief Financial Officer Roy Baynes - Director Roelof F. Botha - Director Peer Information Natera, Inc. (CHCR) Natera, Inc. (ESRX) Natera, Inc. (MYDP) Natera, Inc. (COR) Natera, Inc. (GBCS) Natera, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 632307104 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 137.25 Most Recent Split Date: (:1) Beta: 1.74 Market Capitalization: $26,421.61 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.33 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.96 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 21.09 Price/Cash Flow: - Price / Sales: 13.45 EPS Growth vs. Year Ago Period: -146.67% vs. Previous Quarter: -48.00% Sales Growth vs. Year Ago Period: 32.24% vs. Previous Quarter: 8.92% ROE 09/30/25 - - 06/30/25 - -22.22 03/31/25 - -18.29 ROA 09/30/25 - - 06/30/25 - -15.03 03/31/25 - -11.68 Current Ratio 09/30/25 - - 06/30/25 - 3.72 03/31/25 - 3.87 Quick Ratio 09/30/25 - - 06/30/25 - 3.58 03/31/25 - 3.74 Operating Margin 09/30/25 - - 06/30/25 - -12.89 03/31/25 - -10.36 Net Margin 09/30/25 - - 06/30/25 - -12.89 03/31/25 - -10.36 Pre-Tax Margin 09/30/25 - - 06/30/25 - -12.90 03/31/25 - -10.34 Book Value 09/30/25 - - 06/30/25 - 9.13 03/31/25 - 9.17 Inventory Turnover 09/30/25 - - 06/30/25 - 14.73 03/31/25 - 15.14 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©